Get the Stockscreener App
2.81
1.08%
0.03
After Hours:
2.86
0.05
+1.78%
Adial Pharmaceuticals Inc stock is traded at $2.81, with a volume of 46,731.
It is up +1.08% in the last 24 hours and up +9.77% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
See More
Previous Close:
$2.78
Open:
$2.74
24h Volume:
46,731
Relative Volume:
0.11
Market Cap:
$6.15M
Revenue:
-
Net Income/Loss:
$-7.77M
P/E Ratio:
-0.2837
EPS:
-9.9046
Net Cash Flow:
$-6.52M
1W Performance:
+2.93%
1M Performance:
+9.77%
6M Performance:
-50.66%
1Y Performance:
-78.13%
1-Day Range:
$2.74
$2.8799
1-Week Range:
$2.50
$2.8799
52-Week Range:
$1.31
$18.90
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.81 | 6.08M | 0 | -7.77M | -6.52M | -9.9046 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Adial Pharmaceuticals Inc (ADIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Adial Pharmaceuticals Inc (ADIL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adial Pharmaceuticals Inc (ADIL) Institutional Confidence - TradingKey
Adial Pharmaceuticals Inc (ADIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ADIL|Adial Pharmaceuticals Inc|Price:2.780|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
ADIL|Adial Pharmaceuticals Inc|Price:2.859|Chg%:+0.169 - TradingKey
Adial Pharmaceuticals, Inc Revenue Breakdown – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Adial Pharmaceuticals (ADIL) Slides 1.09% as Stock Tests Key Support ZoneExhaustion Gap - dars.gov.et
Adial Pharmaceuticals (ADIL) Edges Higher as Shares Test Key Resistance ZoneVolume Profile - dars.gov.et
Adial Pharmaceuticals (ADIL) Slides 3.57%: Testing Key Support Near $2.56Accumulation Line - dars.gov.et
Form 4 Adial Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com South Africa
Coastlands Capital buys $8,690 of Adial Pharmaceuticals stock - Investing.com
Coastlands Capital (NASDAQ: ADIL) buys 3,233 ADIAL shares in open market - Stock Titan
Adial Pharmaceuticals (ADIL) Edges Higher on Potential Breakout Above Key ResistanceInside Day Breakout - dars.gov.et
Form 4 Adial Pharmaceuticals Inc For: 13 July By Investing.com - Investing.com Nigeria
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals By Investing.com - Investing.com South Africa
10% owner Coastlands Capital buys $32,637 in Adial Pharmaceuticals - Investing.com
Coastlands Capital LP (NASDAQ: ADIL) reports new insider share purchases - Stock Titan
Adial Pharmaceuticals (ADIL) Stock Forecast & Analyst Ratings - Moomoo
Adial Pharmaceuticals (ADIL) Hovers Near Support as Biotech Sector Faces PressureRating Change - Bölüm Sonu Canavarı
Price to earnings forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals Inc (ADIL) Reclaims Ground: Up 3.20% to $2.9Wave Extension - dars.gov.et
Price to sales forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Group takes 14.22% position in Adial Pharmaceuticals (ADIL) - Stock Titan
Enterprise value to EBIT forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals By Investing.com - Investing.com Nigeria
Coastlands Capital LP acquires $65,000 in Adial Pharmaceuticals - Investing.com
Form 4 Adial Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada
Adial Pharmaceuticals (ADIL) holder Coastlands Capital adds 25,000 shares - Stock Titan
Price to book forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Enterprise value to revenue forward of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Gains 1.17% as Shares Approach Key Resistance LevelMFI Oversold - dars.gov.et
Coastlands Capital details ADIAL Pharmaceuticals (ADIL) stock and warrant stake - Stock Titan
Insider Conviction: Why Coastlands Capital is Buying Adial Pharmaceuticals Ahead of a Pivotal Phase 3 - Kavout | AI
ADIL stock eyes best day in over 5 years — major pipeline overhaul and $64M raise fuel rally - MSN
Adial Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ADIL) - TradingView
ADIL Forecast — Price Target — Prediction for 2027 - TradingView
Coastlands files 9.98% holding in Adial Pharmaceuticals (ADIL) - Stock Titan
ADIL Stock Eyes Best Day In Over 5 Years — Major Pipeline Overhaul And $64M Raise Fuel Rally - Stocktwits
Net current asset value per share of Adial Pharmaceuticals, Inc – NASDAQ:ADIL - TradingView
Adial Pharmaceuticals (ADIL) Faces Selling Pressure, Testing Key Support LevelsRating Change - dars.gov.et
Adial Pharmaceuticals Inc (ADIL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Adial Pharmaceuticals Inc (ADIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Adial Pharmaceuticals Inc (ADIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adial Pharmaceuticals Inc (ADIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Adial Pharmaceuticals (ADIL) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive EPS Surprise, Yet Shares DeclineInterim Report - dars.gov.et
Adial closes $32 million financing, grants stock to new executives By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing - The Manila Times
Adial Pharmaceuticals (ADIL) CDO adds RSUs, options and preferred shares after Azora merger - Stock Titan
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):